N/A
N=94
Positive Attitudes Concerning Infant Feeding- a Questionnaire for Women Living With HIV
Human Immunodeficiency Virus
Bottom Line
View on ClinicalTrials.gov: NCT03294499 ↗Enrolled (actual)
94
Serious AEs
0.0%
Results posted
Feb 2023
Primary outcome: Primary: Knowledge and Experiences of Breastfeeding Among Women Living With HIV — 58; 25; 0; 11 Participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Questionnaire (Other)
- Age
- Adult · 18+ yrs
- Sex
- Female
- Sponsor
- Imperial College London
- Primary completion
- May 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Knowledge and Experiences of Breastfeeding Among Women Living With HIV |
58; 25; 0; 11; 62; 21 | — |
| PRIMARY Views on Infant Feeding for Women Living With HIV |
89; 38 | — |
Summary
The PACIFY Study is a questionnaire for antenatal(third trimester) and postnatal(three months post delivery) Human Immunodeficiency Virus (HIV) positive women attending clinics in London and Brighton. The current World Health Organisation guidance advises HIV positive women, who are adhering to antiretroviral therapy (ART), to exclusively breastfeed for the first 6 months of the infant's life and continue supplemental breastfeeding for up to 2 years.
This is conflicts with the current British HIV Association guidelines which advise exclusive formula feeding. The reason for this difference is the relative safety of formula feeding in the United Kingdom(UK)against the low but persisting risk of HIV infection through breast-feeding. The aim of the PACIFY study is to explore attitudes towards breastfeeding amongst HIV positive women, who are either pregnant or post-partum. The study will also assess the understanding of current infant feeding guidance by these women and assess their current or recent infant feeding practice. It will also look at whether HIV positive mothers would be willing and able to comply with special monitoring and guidance whilst breastfeeding if the guidelines were to change. The study aims to analyse 100 questionnaires completed over a 3-6 month period.
Eligibility Criteria
Inclusion Criteria
- Age > 18 years
- Able to give written informed consent
- Post-natal and antenatal HIV positive women
Exclusion Criteria
- Age <18 years
- Patients who are unable to consent.
- Women with HIV who have not been pregnant.
Data sourced from ClinicalTrials.gov (NCT03294499). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.